|
J Biol Chem, Vol. 274, Issue 29, 20318-20327, July 16, 1999
Identification of P-glycoprotein Mutations Causing a Loss of
Steroid Recognition and Transport
Quang D.
Vo and
Donald J.
Gruol
From the Sidney Kimmel Cancer Center,
San Diego, California 92121
P-glycoproteins transport a wide variety of
hydrophobic compounds out of cells. While the diversity of transported
molecules suggests a mechanism involving broad specificity, there is
evidence of significant discrimination within given classes of
molecules. One example of this behavior is transport of corticosteroids
by the murine mdr1 P-glycoprotein. The presence of hydroxyl
groups, associated with specific steroid carbon atoms, regulates the
ability of corticosteroids to be transported. This specificity is
demonstrated here by experiments measuring the ability of steroids to
inhibit drug transport. The results indicate that a keto oxygen
associated with the 3- and 20-carbon atoms, as well as a 17-carbon
hydroxyl group, each acts to enhance steroidal P-glycoprotein
inhibitory activity. Moreover, inhibitory steroids can be used for
directed selection of variant cells, expressing mutated P-glycoproteins with a severely impaired ability to transport dexamethasone. The five
mutations, reported here, are located within transmembrane domains
4-6, proximal to the cytoplasmic interface. The altered P-glycoproteins exhibit reduced capacity to be inhibited by specific steroids, suggesting decreased capacity to bind these molecules avidly.
Studies comparing the relative inhibitory activity of a series of
steroids indicate that these mutations alter recognition of the
17 -hydroxyl group and the 20-keto oxygen atom.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. A. De Sousa Peixoto, S. Turban, J. H. Battle, K. E. Chapman, J. R. Seckl, and N. M. Morton
Preadipocyte 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Is a Keto-Reductase and Contributes to Diet-Induced Visceral Obesity in Vivo
Endocrinology,
April 1, 2008;
149(4):
1861 - 1868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Adler and E. Bibi
Determinants of Substrate Recognition by the Escherichia coli Multidrug Transporter MdfA Identified on Both Sides of the Membrane
J. Biol. Chem.,
March 5, 2004;
279(10):
8957 - 8965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Loo, M. C. Bartlett, and D. M. Clarke
Substrate-induced Conformational Changes in the Transmembrane Segments of Human P-glycoprotein. DIRECT EVIDENCE FOR THE SUBSTRATE-INDUCED FIT MECHANISM FOR DRUG BINDING
J. Biol. Chem.,
April 11, 2003;
278(16):
13603 - 13606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Gruol, M. N. King, and M. E. Kuehne
Evidence for the Locations of Distinct Steroid and Vinca Alkaloid Interaction Domains within the Murine mdr1b P-Glycoprotein
Mol. Pharmacol.,
November 1, 2002;
62(5):
1238 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Gruol, J. Bernd, A. E. Phippard, I. Ojima, and R. J. Bernacki
The Use of a Novel Taxane-Based P-Glycoprotein Inhibitor to Identify Mutations That Alter the Interaction of the Protein with Paclitaxel
Mol. Pharmacol.,
July 1, 2001;
60(1):
104 - 113.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. Bello-Reuss, S. Ernest, O. B. Holland, and M. R. Hellmich
Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells
Am J Physiol Cell Physiol,
June 1, 2000;
278(6):
C1256 - C1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|